In one 1999 clinical study, (5) eight test subjects were enrolled to examine the potential of growth hormone secretagogues at different concentrations
Orforglipron, a nonpeptide GLP-1 RA administered once daily, showed dose-dependent efficacy on weight loss in a Phase II trial
In this study we used AutoDecon (23) in our primary analysis because we wanted to assess the effects of tesamorelin on pituitary GH secretion using deconvolution analysis to define and differentiate discrete pituitary secretory episodes from background basal secretion
One study showed that people injecting semaglutide (the active ingredient in Wegovy), which is administered for diabetes or weight loss in the skin of the abdomen, thigh, or upper arm, produced little to no injectionsite pain
In terms of ease of use, sublingual semaglutide may be a better choice for people who have a fear of needles or find injections difficult to manage
Niciu MJ, Ionescu DF, Mathews DC, Richards EM, Zarate CA